Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1038/sj.bjc.6690151 http://scihub22266oqcxt.onion/10.1038/sj.bjc.6690151 10070895/?report=reader!2362649!10070895     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Br+J+Cancer 1999 ; 79 (5-6): 945-51 Nephropedia Template TP {{tp|p=10070895|t=1999. Comparison of the Ki-67 score and S-phase fraction as prognostic variables in soft-tissue sarcoma |pdf=|usr=}}{{10070895}} gab.com Text Comparison of the Ki-67 score and S-phase fraction as prognostic variables in soft-tissue sarcoma JO: Br J Cancer http://www.kidney.de/pget.php?&tw=1&pmid=10070895 #FOAvip Immunohistochemically determined Ki-67 scores and flow cytometrically determined S-phase fractions were successfully evaluated from the primary tumours of 123 patients with soft-tissue sarcoma. All patients had either limb or superficial trunk tumours. Ki-67 score correlated strongly with ploidy, S-phase fraction and grade. Ki-67 did not correlate with the size of the primary tumour. When analysed as a continuous variable, Ki-67 was a stronger predictor of both metastasis-free survival and disease-specific overall survival (P = 0.003 and 0.04 respectively) than was the S-phase fraction (P = 0.06 and 0.07 respectively). We tested the relevance of different cut-point values by dividing the whole material into two parts at every 10% (e.g. 10% of patients vs. the remaining 90%, 20% vs. 80%, etc.). We counted the relative risk and confidence interval at all these cut-off points. Ki-67 had good prognostic discriminating power irrespective of the cut-point value, but S-phase fraction lost its prognostic power at higher cut-point values. In conclusion, we found that Ki-67 is a useful prognostic tool in the treatment of soft-tissue sarcoma patients irrespective of the cut-point value. S-phase fraction can be used at lower cut-point values. Twit Text FOAVip Comparison of the Ki-67 score and S-phase fraction as prognostic variables in soft-tissue sarcoma ????Br J Cancer http://www.kidney.de/pget.php?&tw=1&pmid=10070895 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=10070895 #FOAvip English Wikipedia <ref>{{Cite pmid|10070895}}</ref> Comparison of the Ki-67 score and S-phase fraction as prognostic variables in soft-tissue sarcoma #MMPMID10070895 Huuhtanen RL; Blomqvist CP; Wiklund TA; Bohling TO; Virolainen MJ; Tukiainen EJ; Tribukait B; Andersson LC Br J Cancer 1999[Feb]; 79 (5-6): 945-51 PMID10070895show ga Immunohistochemically determined Ki-67 scores and flow cytometrically determined S-phase fractions were successfully evaluated from the primary tumours of 123 patients with soft-tissue sarcoma. All patients had either limb or superficial trunk tumours. Ki-67 score correlated strongly with ploidy, S-phase fraction and grade. Ki-67 did not correlate with the size of the primary tumour. When analysed as a continuous variable, Ki-67 was a stronger predictor of both metastasis-free survival and disease-specific overall survival (P = 0.003 and 0.04 respectively) than was the S-phase fraction (P = 0.06 and 0.07 respectively). We tested the relevance of different cut-point values by dividing the whole material into two parts at every 10% (e.g. 10% of patients vs. the remaining 90%, 20% vs. 80%, etc.). We counted the relative risk and confidence interval at all these cut-off points. Ki-67 had good prognostic discriminating power irrespective of the cut-point value, but S-phase fraction lost its prognostic power at higher cut-point values. In conclusion, we found that Ki-67 is a useful prognostic tool in the treatment of soft-tissue sarcoma patients irrespective of the cut-point value. S-phase fraction can be used at lower cut-point values. |Adolescent[MESH] |Adult[MESH] |Aged[MESH] |Aged, 80 and over[MESH] |Disease-Free Survival[MESH] |Female[MESH] |Follow-Up Studies[MESH] |Humans[MESH] |Ki-67 Antigen/*analysis[MESH] |Male[MESH] |Middle Aged[MESH] |Prognosis[MESH] |Retrospective Studies[MESH] |S Phase[MESH] |Sarcoma/classification/genetics/mortality/*pathology[MESH] |Skin Neoplasms/classification/genetics/mortality/pathology[MESH] |Survival Rate[MESH]Comparison of the Ki-67 score and S-phase fraction as prognostic varia(epmc).pdf DeepDyve Pubget Overpricing